<qa>  What is evidence of clinically significant disease that could affect the participants safety?17. Evidence of clinically significant disease e.g., cardiovascular, respiratory, gastrointestinal, renal disease that in the opinion of the investigators could affect the participants safety or interfere with the study assessments. 